These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25462557)

  • 1. Virtual screening in small molecule discovery for epigenetic targets.
    Li GB; Yang LL; Yuan Y; Zou J; Cao Y; Yang SY; Xiang R; Xiang M
    Methods; 2015 Jan; 71():158-66. PubMed ID: 25462557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries.
    Pham-The H; Casañola-Martin G; Diéguez-Santana K; Nguyen-Hai N; Ngoc NT; Vu-Duc L; Le-Thi-Thu H
    SAR QSAR Environ Res; 2017 Mar; 28(3):199-220. PubMed ID: 28332438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel potential scaffold for class I HDACs inhibition: An in-silico protocol based on virtual screening, molecular dynamics, mathematical analysis and machine learning.
    Fan C; Huang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(3):800-806. PubMed ID: 28705738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
    Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
    J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic drugs that do not target enzyme activity.
    Owen DR; Trzupek JD
    Drug Discov Today Technol; 2014 Jun; 12():e29-34. PubMed ID: 25027371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structure-based virtual screening approach toward the discovery of histone deacetylase inhibitors: identification of promising zinc-chelating groups.
    Park H; Kim S; Kim YE; Lim SJ
    ChemMedChem; 2010 Apr; 5(4):591-7. PubMed ID: 20157916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
    Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
    J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.
    Furdas SD; Kannan S; Sippl W; Jung M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a series of small molecules as potent histone deacetylase inhibitors.
    Zhang L; Wang X; Li X; Xu W
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):333-7. PubMed ID: 23534931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Virtual Screening.
    Li Q; Shah S
    Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validation.
    Kannan S; Melesina J; Hauser AT; Chakrabarti A; Heimburg T; Schmidtkunz K; Walter A; Marek M; Pierce RJ; Romier C; Jung M; Sippl W
    J Chem Inf Model; 2014 Oct; 54(10):3005-19. PubMed ID: 25243797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
    Bayo J; Dalvi MP; Martinez ED
    Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and development of DNA methyltransferase inhibitors using in silico approaches.
    Medina-Franco JL; Méndez-Lucio O; Dueñas-González A; Yoo J
    Drug Discov Today; 2015 May; 20(5):569-77. PubMed ID: 25526932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular fingerprint similarity search in virtual screening.
    Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Garcia-Vallvé S; Pujadas G
    Methods; 2015 Jan; 71():58-63. PubMed ID: 25132639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lazy learning-based QSAR classification study for screening potential histone deacetylase 8 (HDAC8) inhibitors.
    Cao GP; Arooj M; Thangapandian S; Park C; Arulalapperumal V; Kim Y; Kwon YJ; Kim HH; Suh JK; Lee KW
    SAR QSAR Environ Res; 2015; 26(5):397-420. PubMed ID: 25986171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic assays for chemical biology and drug discovery.
    Gul S
    Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer- and structure-based lead design for epigenetic targets.
    Heinke R; Carlino L; Kannan S; Jung M; Sippl W
    Bioorg Med Chem; 2011 Jun; 19(12):3605-15. PubMed ID: 21316248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical virtual screening approaches in small molecule drug discovery.
    Kumar A; Zhang KY
    Methods; 2015 Jan; 71():26-37. PubMed ID: 25072167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BEAR, a novel virtual screening methodology for drug discovery.
    Degliesposti G; Portioli C; Parenti MD; Rastelli G
    J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.